In June, Promega proudly announced the ten winners of the 2024 Promega iGEM Grant. These extraordinary teams have been hard at work preparing for the iGEM Grand Jamboree, which will take place from October 23-26, 2024, in Paris, France. We interviewed a handful of this year’s grant recipients to learn more about their projects and journeys they’ve taken to reach this exciting milestone. Below are stories from four of the winning teams.
Author: Anna Bennett
How Artificial Intelligence Revolutionized the 2024 Paris Olympics
At the end of July, many people across the globe were preparing to tune into the two-week, 2024 Olympic Games in Paris, France. The Olympics were slated to feature several high-profile athletes—including Simone Biles (USA, artistic gymnastics), Eluid Kipchoge (Kenya, marathon) and Marta Vieira da Silva (Brazil, football). However, in the lead-up to the Games, the International Olympic Committee (IOC) focused on a secondary player: Artificial Intelligence (AI). The IOC laid out an ambitious AI agenda aimed to enhance athlete performance, ensure fairness and optimize operations. The 2024 Paris Olympics represent a significant leap forward in integrating AI into the world of sports.
“Together, we can unlock AI’s full potential to promote solidarity, further digitalization, improve sustainability and resilience, and reinforce the role of sport in society.” – Olympic AI Agenda
Here, we explore several applications of AI in the 2024 Paris Olympics.
Continue reading “How Artificial Intelligence Revolutionized the 2024 Paris Olympics”Targeting Dark Kinases for Non-Hormonal, Reversible Male Contraceptives
Contraception, or birth control, is an important tool in family planning. Given the fourfold increase in population over the last century1 there is a clear need for more affordable, reversible, and safe methods of contraception. At present, the responsibility of taking contraceptives falls largely on people with female reproductive organs as there is no current method of birth control for people with male reproductive organs. The search for a non-hormonal, male birth control has been an elusive goal in the field of reproductive health.
Recently, a group of scientists from Baylor College of Medicine with contributions from Promega scientists identified a novel compound that 1) inhibits a specific kinase and 2) functions as a reversible male contraceptive. The kinase targeted in this study is the serine/threonine kinase 33 (STK33); a genetic knockout of this gene in male mice is known to cause sterility. The team published their work in Science and utilized a suite of approaches—including DNA-Encoded Libraries (DELs), crystallography, and cellular NanoBRET™ Target Engagement Kinase Assays—to discover a potent inhibitor of STK33 (CDD-2807). The CDD-2807 inhibitor has shown promising results in inducing reversible contraception in male mice, marking a significant milestone in the development of non-hormonal contraceptive options. Let’s dive into the foundation, novel methodology, collaboration, and implications for this work.
Continue reading “Targeting Dark Kinases for Non-Hormonal, Reversible Male Contraceptives”From Tracers to Kinetic Selectivity: Highlights from the Target Engagement in Chemical Biology Symposium
In April 2024, Promega hosted the “Target Engagement in Chemical Biology Symposium” at the Kornberg Center, a research and development hub on Promega’s campus in Madison, Wisconsin. The goal of the symposium was to gather interdisciplinary researchers interested in the field of small molecule target engagement to foster collaboration through knowledge sharing and innovation. The symposium featured a 1.5-day agenda packed with 23 speakers, 4 workshops, poster sessions and social events. Over 130 attendees gathered to participate in the multifaceted event, with participants from different geographic regions and in different research sectors from academia to government to industry.
The symposium highlighted the collective commitment to overcoming the challenges in drug discovery by developing more targeted and efficacious treatments, driven by a shared determination to create innovative solutions that address unmet medical needs. While we cannot share all the exciting research presented at the symposium, we are thrilled to highlight a few talks that exemplify the novel work and collaborative spirit of this research community.
Continue reading “From Tracers to Kinetic Selectivity: Highlights from the Target Engagement in Chemical Biology Symposium”Rooted in Resilience: The Future of Pest-Resistant Crops
Farmers everywhere strive to protect their crops and ensure a stable food supply while minimizing environmental harm. A promising approach to achieving this leverages a plant’s built-in defense mechanisms, reducing the need for chemical interventions. Many geneticists and agronomists lean on technologies that can automate and streamline nucleic acid extraction and pathogen detection to identify naturally pest resistant crops and, ultimately, keep up with the changing agricultural landscape.
Continue reading “Rooted in Resilience: The Future of Pest-Resistant Crops”Transform Your Research Lab with our Comprehensive Automation Resources
In an era where science moves at a rapid pace, integrating automation into your lab is not just beneficial but essential. When you automate your lab, you free up an invaluable resource: time. From scaling up operations and handling increased demand to improving consistency and reducing manual errors, automation can be the key to achieving higher throughput, saving costs, and—most importantly—enabling researchers to focus on the science rather than the process. However, embarking on a lab automation project requires careful planning, clear goals and an understanding of the intricacies involved in automating complex biological workflows.
Continue reading “Transform Your Research Lab with our Comprehensive Automation Resources”Transforming Forensic Science with DNA from Dust
In the evolving field of forensic science, a study by Fantinato et al. has opened new avenues in using DNA extraction and analysis to recover important information from crime scenes. Their work, “The Invisible Witness: Air and Dust as DNA Evidence of Human Occupancy in Indoor Premises,” focuses on extracting DNA from air and dust. This novel approach could revolutionize how crime scenes are investigated, especially in scenarios where traditional evidence—like fingerprints or bodily fluids—is scarce, degraded or has been removed from surfaces.
Continue reading “Transforming Forensic Science with DNA from Dust”Promega qPCR Grant Series #3: Immunotherapy Researcher, Dr. Sabrina Alves dos Reis
In our third and final installment of the Promega qPCR Grant Recipient blog series, we highlight Dr. Sabrina Alves dos Reis, a trained immunotherapy researcher. Her work has focused on developing tools for more accessible cancer therapies using CAR-T cells. Here, we explore Dr. Alves dos Reis’ academic and scientific journeys, highlight influential mentorship and foreshadow her plans for the Promega qPCR grant funds.
Dr. Alves dos Reis’ career began with a strong affinity for biology. As an undergraduate student, she pursued a degree in biological science, where she developed a foundational understanding for designing and developing research projects. As her passion for science heightened, she decided to continue her journey in science, culminating in a PhD at the Fundação Oswaldo Cruz Institute in Rio de Janeiro, Brazil. Her research projects focused on the unexplored territory of adipose tissue as a site for Mycobacterium leprae—or leprosy bacillus—infection. She mentioned that this work piqued her curiosity for improving immunotherapies and laid the foundation for her future in cancer research.
Continue reading “Promega qPCR Grant Series #3: Immunotherapy Researcher, Dr. Sabrina Alves dos Reis “Promega qPCR Grant Series #2: Molecular Biologist, Laura Leighton
Our second installment of the Promega qPCR Grant Recipient blog series highlights Dr. Laura Leighton, a trained molecular biologist and postdoctoral researcher at the Australian Institute for Bioengineering and Nanotechnology. Leighton’s scientific journey features a passion for molecular biology and problem-solving. Her path has been illuminated by mentorship, relationships with fellow scientists and a commitment to creativity in overcoming challenges. Here, we explore her scientific journey, reflect on research lessons and foreshadow her plans for the Promega qPCR grant funds.
Dr. Laura Leighton grew up in a rural area in Far North Queensland, Australia, where she spent her early life exploring critters on the family farm. Her upbringing was infused with a deep connection to the environment, from raising tadpoles in wading pools to observing wildlife and witnessing food grow firsthand. Observing the biology around her ultimately piqued her interest in science from a young age. She then began her academic journey in 2011 at the University of Queensland, Australia. She studied biology while participating in a program for future researchers, which led her to undergraduate research work in several research labs. She dabbled in many research avenues in order to narrow in on her scientific interests all while adding different research tools to her repertoire.
After serving as a research assistant in Dr. Timothy Bredy’s lab, she decided to continue work in this lab and pursue a PhD in molecular biology. During her PhD, Leighton worked on several projects from cephalopod mRNA interference to neurological wiring in mice. The common thread in these projects is Leighton’s passion for the puzzles of molecular biology:
“I also love molecular engineering and the modularity of molecular parts. There’s something really special about stringing together sequence in a DNA editor, then seeing it come to life in a cell,” she says.
Continue reading “Promega qPCR Grant Series #2: Molecular Biologist, Laura Leighton”Promega qPCR Grant Series #1: Marine Plant Ecologist, Dr. Agustín Moreira-Saporiti
Marine seagrasses are submerged flowering plants that form essential underwater meadows, fostering diverse ecosystems and providing a habitat for marine life. Our first Promega qPCR Grant winner and marine ecologist, Dr. Agustín Moreira-Saporiti, plans to continue adding to a fascinating body of work aimed at understanding flowering in marine seagrasses.
Dr. Moreira-Saporiti began his journey into marine plant ecology at the University of Vigo, Spain, where he earned a bachelor’s degree in marine sciences. He then went on to complete a master’s degree at the University of Bremen (Germany) where his thesis focused the ecology of seagrasses in Zanzibar, Tanzania. His passion for marine botany led him down a deeper exploration of marine plants, unraveling the intricate web of ecosystem processes within seagrasses.